ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MYX Mycelx Technologies Corporation

53.50
0.50 (0.94%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mycelx Technologies Corporation LSE:MYX London Ordinary Share COM SHS USD0.025 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.94% 53.50 52.00 55.00 53.50 53.00 53.00 10,000 11:47:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Water Supply 10.03M -3.99M -0.1736 -3.08 12.3M

MyCelx Technologies Corporation Sale of MYCELX property in Duluth, USA (5489P)

18/02/2021 7:00am

UK Regulatory


Mycelx Technologies (LSE:MYX)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Mycelx Technologies Charts.

TIDMMYX TIDMTTM

RNS Number : 5489P

MyCelx Technologies Corporation

18 February 2021

18 February 2021

MYCELX Technologies Corporation (AIM: MYX)

("MYCELX" or the "Company")

Sale of MYCELX property in Duluth, USA

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, announces the sale of its building in Duluth, Georgia, USA. This sale will enable the Company to right-size its office space needs across its three operating locations. The Company will receive a cash consideration of $5.4 million.

The Company has a debt obligation of circa $2.62 million on the property, so the net cash proceeds are expected to be in the range of $2.78 million. The current net book value of the property is $2.87 million, so MYCELX will recognize a financial gain of approximately $2.53 million.

When the building was originally purchased, the Company's engineering and business development capability was based in Duluth. However, now the Company has other offices across the globe and subsequently, personnel have relocated to these locations resulting in vacant office space.

MYCELX plans to convert the equity in the building into cash for working capital purposes and the team will relocate to another office and manufacturing property nearby that will better suit its needs and footprint. The sale of the property is in line with the Company's cost reduction strategy, reducing the overall cost of its office space and disposing of excess capacity.

The sale of the property to Angkawijana, L.L.C. is subject to certain typical completion conditions to closing. Post transaction, the Company expects to have circa $6 million of cash and cash equivalents on the balance sheet. The transaction is expected to close within the next 30 days.

MYCELX has historically had no profits/losses attributable to its Duluth property.

MYCELX recently applied for and received a second $400,000 forgivable loan from the Payroll Protection Program administered by the US Small Business Administration. The funds will be put towards maintaining payroll and other corporate purposes.

For further information please contact:

 
MYCELX Technologies Corporation 
 Connie Mixon, CEO                              Tel: +1 888 306 6843 
 Kim Slayton, CFO 
Canaccord Genuity Limited (Nomad and broker)  Tel: +44 20 7523 8150 
 Henry Fitzgerald-O'Connor 
 Georgina McCooke 
Celicourt 
 Mark Antelme                                   Tel: +44 20 8434 2754 
 Jimmy Lea 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DISGLGDDLDBDGBI

(END) Dow Jones Newswires

February 18, 2021 02:00 ET (07:00 GMT)

1 Year Mycelx Technologies Chart

1 Year Mycelx Technologies Chart

1 Month Mycelx Technologies Chart

1 Month Mycelx Technologies Chart

Your Recent History

Delayed Upgrade Clock